SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders. The company is backed by UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund and Asabys Partners.
Location: Spain
Employees: 11-50
Total raised: $191.9M
Investors 3
| Date | Name | Website |
| - | Asabys Par... | asabys.com... |
| - | Ysios Capi... | ysioscapit... |
| 05.08.2021 | Caixa Capi... | caixacapit... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 11.09.2025 | Series B | $611.07M | - |
| 19.06.2025 | Series B | $135M | - |
| 21.02.2022 | Series A | $56.9M | Asabys Par... |
Mentions in press and media 20
| Date | Title | Description |
| 19.03.2026 | From diversified funding to frontier innovation: the Spanish tech ecosystem | Spanish tech companies raised €3.1 billion in 2025, highlighting a broad and increasingly mature ecosystem. Large late-stage rounds remained strong, alongside a deep base of early and growth-stage funding across sectors. Funding was concent... |
| 18.09.2025 | Capital meets care: 10 venture capital firms transforming healthcare across Europe | Venture capital remains one of the cornerstones of Europe’s innovation landscape, fuelling the growth of startups across every sector. In our last list, we spotlighted 15 VC firms focused on sustainability, underlining how investors are sha... |
| 15.09.2025 | Europe's VC Shift: UK Fights for Lead as Healthtech Soars in 2025 | European venture capital is undergoing significant shifts in 2025. The UK remains a leader, but emerging competition from Germany and France is notable. Healthtech and AI innovation are major investment drivers, securing billions across the... |
| 11.09.2025 | Europe's 10 biggest healthtech deals in H1 2025 | Healthtech continued to demonstrate its strength in Europe in the first half of 2025, attracting €4 billion in funding, around 12 per cent of the €33.7 billion raised across all European tech sectors. Although healthtech accounted for just ... |
| 19.06.2025 | SpliceBio: $135 Million Series B Raised For Expanding Pipeline Of Genetic Medicines | SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, announced the closing of a $135 million Series B financing co-led by new investors EQT Life Sciences a... |
| 13.06.2025 | Multiverse Computing raises €189M to reshape LLMs, Oxford Ionics to be acquired in $1.1B US deal, and VC spring revival | This week we tracked more than 60 tech funding deals worth over €1.1 billion, and over 5 exits, M&A transactions, rumours, and related news stories across Europe. In addition to this week's top financials, we've also indexed the most im... |
| 11.06.2025 | SpliceBio Raises $135M in Series B Funding | SpliceBio, a Barcelona, Spain-based clinical-stage genetic medicines company, raised $135M in Series B funding. The round was led by EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing ... |
| 11.06.2025 | EQT Life Sciences Co-Leads USD 135 Million Series B Financing in SpliceBio | EQT Life Sciences Co-Leads USD 135 Million Series B Financing in SpliceBio Wed, Jun 11, 2025 09:30 CET Report this content Financing was co-led by EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as... |
| 11.06.2025 | Top 10 Startup and Tech Funding News – June 11, 2025 | It’s Wednesday, June 11, 2025, and we’re back with your daily tech funding roundup, tracking where capital is flowing and which startups are defining what’s next in fintech, AI, fusion energy, crypto infrastructure, robotics, and beyond. To... |
| 17.10.2023 | As Pfizer slashes revenue projections, Moderna says it “remains comfortable” | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with the latest twist in the GLP-1 saga, some drama in the world of Covid-19 booster sh... |
Show more